Immunicum (Sweden)

ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients

Andrew D.J. Pearson, Claudia Rössig, Giovanni Lesa et al. · European Journal of Cancer · 2020 · 66 citations · Full text

Intratumorally injected pro-inflammatory allogeneic dendritic cells as immune enhancers: a first-in-human study in unfavourable risk patients with metastatic renal cell carcinoma

Anna Laurell, Maria Lönnemark, Einar Brekkan et al. · Journal for ImmunoTherapy of Cancer · 2017 · 58 citations · Full text

Phase 1 Trial With the Cell-Based Immune Primer Ilixadencel, Alone, and Combined With Sorafenib, in Advanced Hepatocellular Carcinoma

Magnus Rizell, Malin Sternby Eilard, Mats Andersson et al. · Frontiers in Oncology · 2019 · 51 citations · Full text

Phase I trial evaluating safety and efficacy of intratumorally administered inflammatory allogeneic dendritic cells (ilixadencel) in advanced gastrointestinal stromal tumors

Robin Fröbom, Erik Berglund, David Berglund et al. · Cancer Immunology Immunotherapy · 2020 · 29 citations · Full text

High‐dose pollen intralymphatic immunotherapy: Two RDBPC trials question the benefit of dose increase

Laila Hellkvist, Eric Hjalmarsson, Dan Weinfeld et al. · Allergy · 2021 · 28 citations · Full text